In a week filled with significant developments, Benzinga analyzed the future prospects of some of the most favored stocks among investors. Here’s a deep dive into top stories featuring Apple, Tesla, Novo Nordisk, Bitcoin, and Shiba Inu’s major stablecoin tease.
On Friday, the Dow Jones Industrial Average soared to a record high as inflation data pointed toward continued progress. Wall Street notched its third consecutive week of gains.
The S&P 500 and Dow each advanced roughly 0.6% throughout the week, while the Nasdaq rose by nearly 1%. The personal consumption expenditures index, the preferred inflation metric for the Federal Reserve, increased by 2.2% year-over-year in August, falling short of economists’ expectations.
This came on the heels of the Federal Reserve’s 0.5% interest rate cut on September 18, marking the first cut in more than four years.
Benzinga provides daily insights on the stocks piquing investors’ interests. Below are some of last week’s standout bullish and bearish analyses that warrant your attention.
Prominent Bullish Stories
In the article “Apple iPhone To Fuel 96% Of 2025 Revenue, Analyst Predicts: A Safer Bet Than AI-Heavy Amazon, Alphabet, Microsoft, Meta?” Anusuya Lahiri forecasts that Apple Inc. (NASDAQ: AAPL) will derive 96% of its 2025 revenue from iPhone sales, positing it as a safer investment compared to AI-centric giants like Amazon.com Inc. (NASDAQ: AMZN), Alphabet Inc. (NASDAQ: GOOG), and Microsoft Corp. (NASDAQ: MSFT). This analysis underscores Apple’s stability amidst tech volatility.
Aniket Verma’s report, “Shiba Inu Soars 29% On SHI Stablecoin Update: Lead Developer Shytoshi Kusama Teases Breakout,” sheds light on Shytoshi Kusama hinting at the imminent launch of the SHI stablecoin. This development is pivotal for Shibarium, infusing enthusiasm into the Shiba Inu ecosystem (NYSE: SHIB/USD).
Vandana Singh, in her piece “Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users,” analyzes a study indicating that Novo Nordisk A/S (NYSE: NVO)’s semaglutide, marketed as Ozempic and Wegovy, could reduce the risk of opioid overdose in type 2 diabetic patients with opioid use disorder.
Other notable bullish stories include:
- After Fed Rate Cuts, Is Tesla, Nvidia, Apple, Or Amazon The Best Investment? Poll Reveals Top Magnificent 7 Stock
- Billionaire Tech CEO Makes Cameo In Zuckerberg’s Meta Connect Show
- Palantir And APA Amp Up AI Alliance: Multi-Million Dollar Deal To Transform Oil & Gas Operations
Key Bearish Insights
In their report “Tesla Bull Dampens Enthusiasm Regarding 10/10 Robotaxi Event But Here’s What Would Take To Strengthen Fledgling Stock Recovery”, Shanthi Rexaline covers Gary Black’s cautious outlook on Tesla Inc’s (NASDAQ: TSLA) upcoming Robotaxi event as a stock catalyst. Nonetheless, they highlight the potential of a sub-$30K compact EV to boost Tesla’s long-term growth.
Ananya Gairola’s article, “CrowdStrike Executive Struck By Regret In House Hearing, Says Company Determined To Prevent Instances Like Microsoft Outage From Repeating,” reveals Adam Meyers of CrowdStrike Holdings Inc. (NASDAQ: CRWD)’s apology to lawmakers regarding a global outage brought on by a faulty Microsoft software update, promising to avoid future incidents.
Finally, in “Peter Schiff Wants To Know If Bitcoin Fans Really Care About King Crypto Underperforming Gold,” Aniket Verma brings attention to Peter Schiff‘s criticism of Bitcoin (CRYPTO: BTC/USD) investors for overlooking Bitcoin’s 35% decline against gold since November 2021.
More bearish analyses include:
- A ‘Deflationary Nuclear Bomb’ Is Ticking, Warns Economist, Even As Inflation Risks Wane: ‘Cheaper It Gets, Cheaper Everything Gets’
- Treasury Bond ETF Under Pressure Ahead Of Key Inflation Data: What Investors Should Know
- American Eagle Sues Amazon for Trademark Infringement: Report
Stay updated on all the latest market trends and trading insights by following Benzinga on Twitter.
Image created using artificial intelligence via Midjourney.
This content was partially developed with the assistance of AI tools and reviewed by Benzinga editors.
© 2024 Benzinga.com. Benzinga does not offer investment advice. All rights reserved.
Click here for more trading tips and strategies.
Discover more from Make Money Online and Work From Anywhere
Subscribe to get the latest posts sent to your email.
